{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:44:33Z","timestamp":1760298273427},"reference-count":34,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2010]]},"DOI":"10.1536\/ihj.51.264","type":"journal-article","created":{"date-parts":[[2010,8,12]],"date-time":"2010-08-12T06:06:05Z","timestamp":1281593165000},"page":"264-271","source":"Crossref","is-referenced-by-count":5,"title":["Clinical Course and Outcome of Heart Transplant Recipients  Single Center Experience at the National Cardiovascular Center in Japan"],"prefix":"10.1536","volume":"51","author":[{"given":"Noboru","family":"Oda","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cardiovascular Center"},{"name":"Department of Cardiovascular Medicine, Hiroshima University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko S.","family":"Kato","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cardiovascular Center"},{"name":"Department of Organ Transplantation, National Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuo","family":"Komamura","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cardiovascular Center"},{"name":"Department of Organ Transplantation, National Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihisa","family":"Hanatani","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cardiovascular Center"},{"name":"Department of Organ Transplantation, National Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Mano","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cardiovascular Center"},{"name":"Department of Organ Transplantation, National Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiko","family":"Hashimura","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Asakura","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuo","family":"Niwaya","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, National Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiro","family":"Funatsu","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, National Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junjiro","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, National Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyoichi","family":"Wada","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, National Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuji","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"Department of Clinical Physiology, National Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hatsue","family":"Ishibashi-Ueda","sequence":"additional","affiliation":[{"name":"Department of Pathology, National Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukiko","family":"Nakano","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Hiroshima University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuki","family":"Kihara","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Hiroshima University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masafumi","family":"Kitakaze","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2009.08.014"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Jaski BE, Kim JC, Naftel DC, <i>et al<\/i>. Cardiac transplant outcome of patients supported on left ventricular assist device vs. intravenous inotropic therapy. J Heart and Lung Transplant 2001; 20: 449-56.","DOI":"10.1016\/S1053-2498(00)00246-1"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Hori M, Yamamoto K, Kodama K, <i>et al<\/i>. Successful launch of cardiac transplantation in Japan. Osaka University Cardiac Transplant Program. Jpn Circ J 2000; 64: 326-32. (Review)","DOI":"10.1253\/jcj.64.326"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Osada K, Imaizumi T; Heart Transplant Candidate Registry Committee of the Japanese Circulation Society. Special report from the heart transplant candidate registry committee in Japan. J Heart Lung Transplant 2005; 24: 810-4.","DOI":"10.1016\/j.healun.2004.05.011"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Kitamura S, Nakatani T, Yagihara T, <i>et al<\/i>. Cardiac transplantation under new legislation for organ transplantation in Japan: report of two cases. Jpn Circ J 2000; 64: 333-9. (Review)","DOI":"10.1253\/jcj.64.333"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. St Goar FG, Pinto FJ, Alderman EL, <i>et al<\/i>. Intracoronary ultrasound in cardiac transplant recipients. In vivo evidence of &ldquo;angiographically silent&rdquo; intimal thickening. Circulation 1992; 85: 979-87.","DOI":"10.1161\/01.CIR.85.3.979"},{"key":"7","unstructured":"7. Billingham ME, Cary NR, Hammond ME, <i>et al<\/i>. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation. J Heart Transplant 1990; 9: 587-93."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Wu GW, Kobashigawa JA, Fishbein MC, <i>et al<\/i>. Asymptomatic antibody-mediated rejection after heart transplantation predicts poor outcomes. J Heart Lung Transplant 2009; 28: 417-22.","DOI":"10.1016\/j.healun.2009.01.015"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Gupta S, Mitchell JD, Lavingia B, <i>et al<\/i>. Utility of routine immunofluorescence staining for C4d in cardiac transplant recipients. J Heart Lung Transplant 2009; 28: 776-80.","DOI":"10.1016\/j.healun.2009.05.007"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. de Gouveia RH, Vitorino E, Ramos S, <i>et al<\/i>. C4d-the witness of humoral rejection. Transplant Proc 2009; 41: 866-7.","DOI":"10.1016\/j.transproceed.2009.02.002"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Jenkins GH, Singer DR. Hypertension in thoracic transplant recipients. J Hum Hypertens 1998; 12: 813-23. (Review)","DOI":"10.1038\/sj.jhh.1000710"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Roche SL, Kaufmann J, Dipchand AI, Kantor PF. Hypertension after pediatric heart transplantation is primarily associated with immunosuppressive regimen. J Heart Lung Transplant 2008; 27: 501-7.","DOI":"10.1016\/j.healun.2008.01.018"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2003.08.063"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Arora S, Aukrust P, Andreassen A, <i>et al<\/i>. The prognostic importance of modifiable risk factors after heart transplantation. Am Heart J 2009; 158: 431-6.","DOI":"10.1016\/j.ahj.2009.05.036"},{"key":"15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199509073331003"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Cantarovich M, Hirsh A, Alam A, <i>et al<\/i>. The clinical impact of an early decline in kidney function in patients following heart transplantation. Am J Transplant 2009; 9: 348-54.","DOI":"10.1111\/j.1600-6143.2008.02490.x"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Chen PL, Chang HH, Chen IM, <i>et al<\/i>. Malignancy after heart transplantation. J Chin Med Assoc 2009; 72: 588-93.","DOI":"10.1016\/S1726-4901(09)70434-4"},{"key":"18","unstructured":"18. Atkinson JB, Wudel JH, Hoff SJ, Stewart JR, Frist WH. Amlodipine reduces graft coronary artery disease in rat heterotopic cardiac allografts. J Heart Lung Transplant 1993; 12: 1036-43."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Leenen FH, Coletta E, Davies RA. Prevention of renal dysfunction and hypertension by amlodipine after heart transplant. Am J Cardiol 2007; 100: 531-5.","DOI":"10.1016\/j.amjcard.2007.03.058"},{"key":"20","unstructured":"20. Kobashigawa J. What is the optimal prophylaxis for treatment of cardiac allograft vasculopathy? Curr Control Trials Cardiovasc Med 2000; 1: 166-71."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Kato T, Tokoro T, Namii Y, <i>et al<\/i>. Early introduction of HMG-CoA reductase inhibitors could prevent the incidence of transplant coronary artery disease. Transplant Proc 2000; 32: 331-3.","DOI":"10.1016\/S0041-1345(99)00971-9"},{"key":"22","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-08-1098"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Reed EF, Demetris AJ, Hammond E, <i>et al<\/i>. International Society for Heart and Lung Transplantation. Acute antibody-mediated rejection of cardiac transplants. J Heart Lung Transplant 2006; 25: 153-9. (Review)","DOI":"10.1016\/j.healun.2005.09.003"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Wada K, Takada M, Kotake T, <i>et al<\/i>. Limited sampling strategy for mycophenolic acid in Japanese heart transplant recipients: comparison of cyclosporin and tacrolimus treatment. Circ J 2007; 71: 1022-8.","DOI":"10.1253\/circj.71.1022"},{"key":"25","unstructured":"25. Meiser BM, Groetzner J, Kaczmarek I, <i>et al<\/i>. Tacrolimus or cyclosporine: which is the better partner for mycophenolate mofetil in heart transplant recipients? Transplantation 2004; 78: 591-8."},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Kobashigawa JA, Miller LW, Russell SD, <i>et al<\/i>. Tacrolimus with mycophenolate mofetil (MMF) or sirolimus vs. cyclosporine with MMF in cardiac transplant patients: 1-year report. Am J Transplant 2006; 6: 1377-86.","DOI":"10.1111\/j.1600-6143.2006.01290.x"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Oda N, Kato TS, Hanatani A, <i>et al<\/i>. Reversible posterior leukoencephalopathy syndrome (RPLS) in a Heart Transplant Recipients Treated by Conversion from Cyclosporine A to Tacrolimus. Nippon Naika Gakkai Zasshi 2010. (in press)","DOI":"10.2169\/internalmedicine.49.3012"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Pascual J. Post-transplant lymphoproliferative disorder--the potential of proliferation signal inhibitors. Nephrol Dial Transplant 2007; 22: i27-35. (Review)","DOI":"10.1093\/ndt\/gfm088"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Kato TS, Sasaoka T, Wada K, Nakatani T, Komamura K. Reversible Severe Synovitis Associated with Everolimus. J Heart Lung Transplant 2010; 49. (in press)","DOI":"10.1016\/j.healun.2010.01.001"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Dew MA, DiMartini AF, De Vito Dabbs A, <i>et al<\/i>. Rates and risk factors for nonadherence to the medical regimen after adult solid organ transplantation. Transplantation 2007; 83: 858-73.","DOI":"10.1097\/01.tp.0000258599.65257.a6"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Dew MA, Kormos RL, Roth LH, Murali S, DiMartini A, Griffith BP. Early post-transplant medical compliance and mental health predict physical morbidity and mortality one to three years after heart transplantation. J Heart Lung Transplant 1999; 18: 549-62.","DOI":"10.1016\/S1053-2498(98)00044-8"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Mehra MR, Uber PA, Scott RL, Park MH. Ethnic disparity in clinical outcome after heart transplantation is abrogated using tacrolimus and mycophenolate mofetil-based immunosuppression. Transplantation 2002; 74: 1568-73.","DOI":"10.1097\/00007890-200212150-00014"},{"key":"33","unstructured":"33. Bennett LE, Keck BM, Hertz MI, Trulock EP, Taylor DO. Worldwide thoracic organ transplantation: a report from the UNOS\/ISHLT international registry for thoracic organ transplantation. Clin Transpl 2001: 25-40."},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Swinnen LJ, Costanzo-Nordin MR, Fisher SG, <i>et al<\/i>. Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients. N Engl J Med 1990; 323: 1723-8.","DOI":"10.1056\/NEJM199012203232502"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/ihj\/51\/4\/51_4_264\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T06:51:12Z","timestamp":1618815072000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/ihj\/51\/4\/51_4_264\/_article"}},"subtitle":["Single Center Experience at the National Cardiovascular Center in Japan"],"short-title":[],"issued":{"date-parts":[[2010]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.51.264","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010]]}}}